Walgreens Boots Alliance has reportedly sold shares in
Cencora, resulting in proceeds of approximately $1.1 billion.
Frank Clyburn has been elected to the company's board of directors.
Blue Trust Inc. and the
Czech National Bank have acquired shares of Cencora.
Sumitomo Mitsui Trust Holdings Inc. and
Envestnet Portfolio Solutions Inc. have offloaded shares of the company.
The
price of Cencora has seen significant fluctuations, hitting 52-week highs while also experiencing sharp declines. These changes have been attributed to various reasons including the company's financial performance, speculative evaluations, and insider activities. The company has a consensus broker recommendation of a 'moderate buy'.
Cencora's Q3 earnings beat estimates, with a positive outlook for 2024. Several firms including ORG Partners LLC and Dynamic Advisor Solutions LLC have taken positions in the company, and the company's intrinsic value is reportedly poised to be significantly above its share price.
On the other hand, Walgreens has made further cuts to its stake in Cencora and internal sales have been noted, as insiders like Steven Collis and Gina Clark sold their shares. Cencora's performance has been analysed compared to the healthcare sector and its performance metrics have been the subject of several discussions.
Cencora COR News Analytics from Wed, 31 Jan 2024 08:00:00 GMT to Sun, 18 Aug 2024 17:54:51 GMT -
Rating 4
- Innovation -1
- Information 8
- Rumor 7
